The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with ...

Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only ...

Genentech's ranibizumab injection (Susvimo) has received FDA approval for the treatment of diabetic retinopathy. The ...

One-year results from the Pavilion study showed patients who received Susvimo (ranibizumab) refilled every nine months ...

At ARVO 2025, in Salt Lake City, Utah, David Almeida, MD, MBA, PhD, talked about 12-month results from the PAVIA phase 2 ...

Susvimo is the first and only FDA-approved, continuous delivery treatment shown to maintain vision in people with DR with ...

The FDA approved Susvimo 100 mg/mL to treat diabetic retinopathy, according to a press release from Genentech.The approval was supported by positive 1-year data from the phase 3 Pavilion study in ...

Thanks to advancements in early detection and treatment options, it's possible to live a long and healthy life after being ...

Susvimo is also approved to treat diabetic macular edema and age-related macular degeneration, and the medication, ...

Basel: Roche has received approval from the US Food and Drug Administration (FDA) for Susvimo (ranibizumab injection) 100 ...

In patients with diabetic retinopathy, obstructive sleep apnea increases the risk for proliferative diabetic retinopathy, intravitreal injection, and stroke.